Tarlatamab-dlle (intravenous route)
Available brands
Imdelltra
About this medication
Tarlatamab-dlle injection is used to treat extensive stage small cell lung cancer (ES-SCLC) that has spread throughout the lung or to other parts of the body in patients who have received other cancer medicines (eg, platinum) that did not work well. This medicine is to be given only by or under the supervision of your doctor. This product is available in the following dosage forms:
Before using this medication
In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For this medicine, the following should be considered: Tell your doctor if you have ever had any unusual or allergic reaction to this medicine or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully. Appropriate studies have not been performed on the relationship of age to the effects of tarlatamab-dlle injection in the pediatric population. Safety and efficacy have not been established. Appropriate studies performed to date have not demonstrated geriatric-specific problems that would limit the usefulness of tarlatamab-dlle injection in the elderly. There are no adequate studies in women for determining infant risk when using this medication during breastfeeding. Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. Tell your healthcare professional if you are taking any other prescription or nonprescription (over-the-counter [OTC]) medicine. Certain medicines should not be used at or around the time of eating food or eating certain types of food since interactions may occur. Using alcohol or tobacco with certain medicines may also cause interactions to occur. Discuss with your healthcare professional the use of your medicine with food, alcohol, or tobacco. The presence of other medical problems may affect the use of this medicine. Make sure you tell your doctor if you have any other medical problems, especially:
How to use this medication
Medicines used to treat cancer are very strong and can have many side effects. Before using this medicine, make sure you understand all the risks and benefits. It is important for you to work closely with your doctor during your treatment. A nurse or other trained health professional will give you this medicine. It is given through an IV catheter that is placed into one of your veins. It must be given slowly, so the IV will have to remain in place for at least 1 hour. Your treatment schedule is divided into cycles that are usually 28 days long. You will receive this medicine on a "step-up dosing schedule." This means you will receive a smaller dose on Day 1 of your first treatment cycle. Then, you will receive the full treatment dose on Day 8 and Day 15 of Cycle 1. You will receive your full dose every 2 weeks after Day 15 of Cycle 1. Your doctor will ask you to stay in a medical facility during treatment with this medicine: This medicine comes with a Medication Guide. Read and follow these instructions carefully. Ask your doctor if you have any questions. Your may also receive extra fluids and other medicines (eg, steroid medicine) within 1 hour before or immediately after starting treatment with this medicine.
Disclaimer: August is a health information platform and its responses don't constitute medical advise. Always consult with a licenced medical professional near you before making any changes.